Close
Nordic 9Nordic 9

Birk Venture (investor - Venture Capital)

Norway birkventure.no
See something wrong or missing? Let us know
Offices:Oslo

Birk Venture is a Norwegian venture company focusing on the life science industry.

Average round investment:626k USD
Average number per year:1.3
Distribution: 2020 (1)2019 (1)2011 (2)
Portfolio companies: Norway Zelluna Immunotherapy AsNorway APIM Therapeutics
Mostly invests in: Norway Norway (4) Biotech (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Birk Venture mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Birk Venture

Name Criteria
Norway Ro Invest
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Mayfield Fund
65%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Finland Sauli Törmälä
65%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden STING
65%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Sweden PÄAB
63%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Spain Chamberí Ventures
62%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Denmark Accelerace
60%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Norway Raman Bhatnagar
59%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway Christian Hager
59%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Haflo AB
58%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Top